BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19017170)

  • 1. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
    Brines M; Cerami A
    J Intern Med; 2008 Nov; 264(5):405-32. PubMed ID: 19017170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.
    Brines M
    Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pleiotropic effects of erythropoietin].
    Kes P; Basić-Jukić N; Furić-Cunko V
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
    Fliser D; Haller H
    Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue.
    Rotter R; Menshykova M; Winkler T; Matziolis G; Stratos I; Schoen M; Bittorf T; Mittlmeier T; Vollmar B
    J Orthop Res; 2008 Dec; 26(12):1618-26. PubMed ID: 18634017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model.
    Kitamura H; Isaka Y; Takabatake Y; Imamura R; Suzuki C; Takahara S; Imai E
    Nephrol Dial Transplant; 2008 May; 23(5):1521-8. PubMed ID: 18194980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin, erythropoiesis and beyond.
    Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172.
    Dumont F; Bischoff P
    Expert Opin Ther Pat; 2010 May; 20(5):715-23. PubMed ID: 20192905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin is a multifunctional tissue-protective cytokine.
    Erbayraktar S; Yilmaz O; Gökmen N; Brines M
    Curr Hematol Rep; 2003 Nov; 2(6):465-70. PubMed ID: 14561390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
    Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
    Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
    Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
    Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells.
    Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB
    Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?
    Grasso G; Sfacteria A; Cerami A; Brines M
    Neuroscientist; 2004 Apr; 10(2):93-8. PubMed ID: 15070483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus.
    Hamed S; Bennett CL; Demiot C; Ullmann Y; Teot L; Desmoulière A
    Wound Repair Regen; 2014; 22(1):23-33. PubMed ID: 24471742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin promotes survival and regeneration of insect neurons in vivo and in vitro.
    Ostrowski D; Ehrenreich H; Heinrich R
    Neuroscience; 2011 Aug; 188():95-108. PubMed ID: 21600963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin--a new therapy in cerebral ischemia?].
    Kalialis LV; Olsen NV
    Ugeskr Laeger; 2003 Jun; 165(24):2477-81. PubMed ID: 12872467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
    Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH
    J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin and myocardial protection: what's new?
    Joyeux-Faure M; Godin-Ribuot D; Ribuot C
    Fundam Clin Pharmacol; 2005 Aug; 19(4):439-46. PubMed ID: 16011730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.